In transgenic mice, overexpression of p100/52 result in a delay of mammary gland development, which is accompanied with over expression of cyclin D1, MMP2, MMP9 and COX-2 expression and results in the mice developing multiple tumours [73]. The gene discussed is NFKB2; the disease is neoplasm.